Press release
Osteoporosis Treatment Market Analysis, Trends, Growth, Research And Forecast 2032
Osteoporosis Treatment Market
The Business Research Company's Osteoporosis Treatment Global Market Report 2023 identifies the increasing prevalence and incidence of osteoporosis as the major driver for the osteoporosis treatment market's growth in the forecast period.Osteoporosis is a bone disease that manifests when bone strength and composition change or when bone mass and mineral density drop. Most osteoporosis drugs function by slowing down the rate at which your bones deteriorate. At the same time, hormone-based treatments such as estrogen can help maintain bone density, especially when taken immediately after menopause.
The global osteoporosis treatment market is expected to grow from $12.47 billion in 2022 to $13.16 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The osteoporosis treatment market is expected to reach $15.77 billion in 2027 at a CAGR of 4.6%.
Download Free Sample Of Osteoporosis Treatment Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12166&type=smp
Major competitors in the osteoporosis treatment market are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Allergan plc, Teva Pharmaceuticals Industries Ltd., Biogen Inc., Daiichi Sankyo company Ltd, Dr. Reddy's Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Covis Pharmaceuticals Inc., Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., Actavis plc, and EffRx Pharmaceuticals SA.
A key trend in the osteoporosis treatment market includes product innovation. Major companies operating in the osteoporosis treatment market are adopting recent technologies to sustain their position in the market. For instance, in January 2021, Theramex, a UK-based pharmaceutical company, launched Livogiva, a new teriparatide pre-filled pen for treating severe osteoporosis. Livogiva is a biosimilar of the Forsteo reference drug teriparatide, and in phase III clinical investigation, individuals with severe osteoporosis who received treatment for six months showed therapeutic equivalence.
Read More On The Global Osteoporosis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report
The osteoporosis treatment market is segmented -
• By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
• By Route of Administration: Oral, Injectable, Other Routes
• By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the osteoporosis treatment market.
The Business Research Company's "Global Osteoporosis Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Osteoporosis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166
The Table Of Content For The Osteoporosis Treatment Market Include:
1. Executive Summary
2. Osteoporosis Treatment Market Characteristics
3. Osteoporosis Treatment Market Trends And Strategies
4. Osteoporosis Treatment Market - Macro Economic Scenario
……
32. Global Osteoporosis Treatment Market Competitive Benchmarking
33. Global Osteoporosis Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Osteoporosis Treatment Market
35. Osteoporosis Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Treatment Market Analysis, Trends, Growth, Research And Forecast 2032 here
News-ID: 3319311 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In Osteoporosis Treatment Market: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Osteoporosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the realm of osteoporosis treatments, the market has seen consistent expansion recently, projected to increase its valuation from $13.96 billion in 2024 to $14.57 billion come 2025, reflecting a compound annual growth rate of…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Postmenopausal Osteoporosis Treatment Market Through 2025?
Valuations for the marketplace addressing postmenopausal osteoporosis treatments have demonstrated consistent upward movement throughout the preceding years, projecting an expansion from a figure of $10.1 billion in 2024 to an anticipated $10.54 billion by 2025, reflecting…
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
